Abstract In our study, molecular docking and molecular dynamics (MD) simulations were performed in order to explore the interactions between human insulin and b-cyclodextrin (b-CD). Molecular docking study was performed using the Autodock v4.2 program to determine the number of b-CD molecules that adhere to the binding sites of insulin. A random structure docking approach using an initial ratio of 1:1 insulin-b-CD was conducted and from these, additional b-CDs were added. Molecular docking results revealed that a maximum of four b-CDs are able to bind to the insulin structure with the 1:3 insulin-b-CD ratio producing the lowest binding free energy. The docked conformations showed that hydrophobic interactions played a crucial role in insulin-b-CD conformational stability in addition to the formation of hydrogen bonds. A 50 ns MD simulation was further conducted using an NPT ensemble to verify the results obtained by molecular docking. The analysis of the MD simulation results of the 1:3 insulin-b-CD formation system conclude that a good interaction exists between insulin and b-CDs and the RMSD value obtained was 4.00 ± 0.50 Å . The RMSF profiles of insulin in the 1:3 insulin-b-CD formation also show reduced amino acid residues flexibility as compared to the free insulin system. The theoretical results indicated the presence of significant interactions between insulin and b-CD which could provide interesting insights into an insulin formulation.
Introduction
During the last decade, approximately 300 million people worldwide were affected by Diabetes Mellitus (DM) [1] and Asian countries represent more than 60 % of that diabetic population [2] . Patients affected by diabetes face acute and chronic complications such as cardiovascular disease, diabetic retinopathy, lipid disorders and hypertension [3] . For these reasons, diabetic patients are treated with exercise regimes, dietary measures, oral medicines and insulin injection. Insulin is naturally produced in the pancreas and plays the role of decreasing the glucose level in blood [4] . Insulin is also produced in the laboratory as the main therapy for certain diabetic patients. Insulin has important roles on the metabolic energy, cell permeability and cellular homeostasis. In fact, insulin is the most crucial physiological factor that controls the glucose cell concentration in the body.
Generally, insulin can be found as monomer, dimer, or hexamer formations. Insulin monomer is made up of two peptide chains, chain A with 21 amino acid residues and chain B with 30 residues. Each monomer is linked together by three disulfide bonds in dimer insulin as shown in Fig. 1 . Insulin exists as a monomer in solution and is stored in the pancreas in the form of dimers and hexamers [5, 6] . The dimer and hexamer forms of insulin are also known to be more resistant to chemical and physical degradations than its monomer form [7] . Monomer insulin is biologically active [8] and is capable of self-association forming dimers and hexamers in biosynthesis and during storage of insulin. However, the monomer insulin is unstable compared to its dimer and hexamers forms, thus, it could be the main reason why researchers used the dimer form of insulin. In addition, monomer insulin forms aggregates and fibrils due to the interactions between the hydrophobic residues in monomers of insulin and this behavior is often associated with the reduction of insulin monomer biological potency [9] .
Conventionally, insulin is administered via injection. This may cause several complications among patients such as needle phobia, skin bulges, allergic reactions, hyperinsulinemia, lipodystrophy development around the injection site and failure of glycemic control due to noncompliance [10, 11] . To prevent these problems, oral delivery formulations of insulin received much attention due to its simplicity and safety. However, there are major hurdles to the effective production of orally delivered insulin which are the degradation of insulin by enzymes in the gastrointestinal tract, low penetration rate through the gastrointestinal membrane and biological and structural instability of insulin in the body [12, 13] . Many research groups are currently working towards the development of an oral insulin formulation via various approaches such as chemical modification [14] , enzyme inhibitors and penetration enhancers [15, 16] by incorporating insulin into carriers such as hydrogels [17] , liposomes [18] , erythrocytes [19] , nanospheres [20] and nanocubicles [21] .
The encapsulation of insulin with b-cyclodextrin (b-CD) could be one of the ways to improve the properties of insulin. b-CD is a cyclic glucose oligosaccharide consisting of seven glucopyranose units that are linked by a-(1, 4) glysosidic bonds [22] . b-CD has a cone-shaped structure with a hydrophilic external and hydrophobic cavity as shown in Fig. 2 . b-CD is capable of forming noncovalent inclusion complexes with various small lipophilic molecules [23] [24] [25] and large biomolecules such as proteins [26] . Proteins such as insulin are usually too bulky to be wholly included into CDs' cavities, however, their hydrophobic side chains can partially penetrate into the CDs' cavity to form noncovalent inclusion complexes [27] . Meanwhile, the hydrophilic side chains of insulin can form polar interactions with the hydroxyl groups of CDs. According to Krauland and Alonso [28] , complexation with b-CD may protect insulin against degradations, suppress aggregations and function alterations. This complexation could improve the absorption of insulin across the biological barriers by perturbing the membrane fluidity and lowering the barrier function [29] . The toxicity profile of CDs for pharmaceutical use has been studied extensively [30] and reviewed [31] . In addition, Bellringer and co-workers reported no pathological evidence of systemic toxicity of b-CD on rats and dogs and indicated that non-toxic effect level was 12,500 and 50,000 ppm, respectively [32] .
Molecular docking is an approach that can be used to find the possible binding sites between receptor and ligand. Several works have been done to evaluate the possible binding sites on insulin via molecular docking. For example, Hadaruga et al. [33] Fig. 1 The numbering scheme for the amino acid residues for the insulin dimer; blue lines represent the disulphide bridge formation. (Color figure online) investigate the possible binding sites between insulin-containing oligopeptide A and B chains with b-CD. Meanwhile, Karplus and co-workers [34] analyzed the binding of Dglucose onto the surface of insulin by using molecular docking and molecular dynamics (MD) simulation. The study proved that the best docked conformers produced stable trajectories in MD simulation. In addition, Berhanu and Masunov [35] reported the investigation on the structural stability and aggregation behavior of wild-type and mutant single-layer insulin aggregates using MD simulation.
This paper reports our investigation on the conformational change of human insulin dimer upon binding with multiple b-CDs and the molecular interactions involved by means of molecular docking and MD as part of our attempt to understand the cyclodextrin behaviour toward human insulin as an oral delivery medium for insulin.
Step by step docking was conducted to determine the maximum number of b-CDs that can be bound to the active sites of insulin. A 50 ns MD simulation was then performed in order to determine the stability of the complex in water as well as the forces responsible in stabilizing the complex.
Computational methods

Molecular docking
The x-ray crystal structure of human insulin dimer (PDB ID:1BEN) was retrieved from Protein Data Bank (www. rcsb.org), while the structure of b-CD was obtained from the literature [36] . The two 4-hydroxylbenzamide ligands and water molecules have been removed from the 1BEN.pdb crystal structure prior to docking study and hydrogen atoms were added to insulin crystal structure. A single molecule b-CD structure was geometrically optimized using the semi-empirical PM3 method which is implemented in the Gaussian 2003 program [37] . The optimized single b-CD structure was then used as the ligand in all docking processes.
Molecular docking of b-CD to the insulin model was carried out using the AutoDock v4.2 software package [38, 39] . Gasteiger charges were computed for each of the molecules. The grid maps were prepared using a 126 9 126 9 126 Å grid box with the distance between two grid points set at 0.375 Å centering on insulin. All rotational bonds in b-CD were set free, while those of insulin were held rigid. The docking studies were carried out using the empirical free energy function and applying the standard protocol of the Lamarckian Genetic Algorithm (LGA), with an initial population of 100 randomly placed individuals and a maximum number of 2.5 9 10 6 energy evaluations, a maximum number of 27,000 generations, a mutation rate of 0.02, a crossover rate of 0.80 and an elitism value of 1. A total of 100 independent docking runs were carried out for each docking processes. The docked conformations were clustered using a tolerance of 2 Å of root-mean-square deviations (RMSD) and were evaluated according to the binding free energy value. The final lowest docked energy conformation is then used for the next run with another b-CD and the docking studies were repeated until the maximum number of b-CDs yield a positive binding free energy value. The best conformations with the lowest docked energy were then selected and analysed using the LigPlot program [40] .
Molecular dynamics simulation details
A 50 ns MD simulations was performed for both the 1:3 insulin-b-CD formation and the free human insulin dimer using GROMACS v4.6.2 program [41, 42] . The initial conformation of 1:3 insulin dimer-b-CD formation was taken from the previous docking results. The GROMOS96 5a36 force field [43] parameters were applied for the insulin b-CD structures and the topology was created based on the available GROMACS database. Both the free insulin dimer and the 1:3 insulin-b-CD formation systems were filled with 8476 SPC water molecules [44] in a 2744.20 Å 3 (64.983 9 64.983 9 64.983 Å 3 ) cubic boxes. The simulation box has a 10 Å spacing distance around the system. To remove bad contacts, energy minimization was performed using the steepest descent algorithm for 1000 steps. In the consecutive steps, equilibrations of the system were conducted in two phases: (1) canonical NVT ensemble, a 100 ps position-restrained of insulin and b-CD simulation at 300 K was carried out using a Berendsen thermostat to ensure the proper stabilization of the temperature; (2) isothermalisobaric NPT ensemble, a 100 ps position-restrained of insulin and b-CD simulation at 300 K and 1 bar was carried out using a Parrinello-Rahman barostat pressure coupling to stabilize the system. These were then followed by a 50 ns MD run without position restraints on the solute at 300 K and 1 bar. The long-range electrostatic interactions were treated using the particle-mesh Ewald (PME) method [45] , with a 12 Å cutoff for van der Waals interactions, a 12 Å cutoff for Coulomb interaction which were updated every 10 steps, and the Lincs algorithm [46] was used for bond constraints to maintain rigid bond lengths. All simulations were simulated in triplicate by randomly assigning initial velocity taken from Maxwell-Boltzman distribution at 298.15 K and computed with a time step of 2 fs, and the coordinates were recorded every 500 steps.
Results and discussion
Molecular docking
The molecular docking study was performed considering four different ratios of human insulin dimer:b-CD (i.e. 1:1, 1:2 1:3 and 1:4). The results of the docking study are summarized in Table 1 and the 3D structure of the insulin-b-CDs formation with binding sites I, II, III and IV is shown in Figs. 3 and 4 . The AutoDock program computed the binding free energy which is composed of the intermolecular energy (van der Waals energy, hydrogen bonding energy, desolvation energy and electrostatic energy) and internal energy [47] . Results show that the 1:3 insulin-b-CD formation has the lowest binding free energy (-7.03 kcal mol -1 ) which was lower than that of 1:4 insulin-b-CD formation (-0.74 kcal mol -1 ). The 1:1 and 1:2 insulin-b-CD formations showed higher binding free energies, -0.56 and -0.18 kcal mol -1 , respectively. The variation in the binding free energies occurs due to the difference in the hydrophobic interactions and hydrogen bonding formation between insulin's amino acid residues with that of b-CD in each conformations which stabilized the system by lowering the binding free energy for the most stable conformation. Figure 4 shows the interactions of the most stable conformation of insulin-b-CD formation at binding sites I, II, III and IV which correspond to the binding sites for the first, second, third and fourth b-CD on insulin by LigPlot analysis. The docking results indicate that the 1:3 insulinb-CD formation produces the most stable conformation in which b-CDs form hydrophobic interactions with a total of 16 amino acids which are Ile10, His31, Glu42, Ile53, Val54, Thr59, Ile61, Ser63, Leu67, Cys79, His82, Leu83, Ala86, Phe97, Tyr98 and Pro100. The formation of hydrogen bonds involved the interactions between the -OH groups of the b-CDs with amino acid residues Asn21, Phe22, Val23, Asn24, Gln25 (2), His26, Glu55, Cys58, Cys62 (2) and Thr99 (5).
The previous study by Hadaruga et al. [30] stated that cystein is not capable of forming complexes with b-CD due to the bonded form of four cystein groups which avoid any of its side chains to function as hydrophobic or hydrophilic amino acids. In this work, docking with the first two b-CDs confirms there is no interaction between cystein and b-CD and the interaction only exist when the third b-CD was docked to insulin whereby the -COOH hydrophilic side chain of Cys58 and Cys62 interacts with the hydroxyl groups at the narrower b-CD rim. Thr99 forms five hydrogen bonds at binding site I and this can be explained as the characteristic of polar amino acids. The result is in agreement with the study by Cooper [48] who reported that the polar amino acids such as tyrosine and threonine were primarily responsible for the interaction between proteins and cyclodextrins. Berman and the co-workers have also reported several crystal structures of carbohydrate-binding proteins making complex with cyclodextrin in the PDB database which confirmed the interactions between cyclodextrin and protein [49] .
In the present study, the isopropyl side chain of Leu67 and Leu83 groups tend to form hydrophobic interactions with b-CD. This is in agreement with Mikami et al. [50] who previously reported the interaction between isopropyl group of a leucine side chain in soybean b-amylase and the OH group from the wider rim of cyclodextrin. The phenylalanine group displays a unique behavior as the Phe22 is involved in the formation of hydrogen bond with b-CD while Phe97 acts as hydrophobic residues towards b-CD. Previously, Yokota et al. [51] reported that phenylalanine in Thermoactinomyces vulgaris R-47 alpha-amylase II was included near the narrow rim of methyl-b-CD.
Docking with the fourth b-CD reveals the formation of hydrophobic contacts between b-CD with His31, Tyr88, Leu64 and Val90. In binding site IV, two more hydrogen bonds formation were observed between b-CD and amino acids Ser30 and Leu89. These additional hydrophobic contacts and hydrogen bond formations however results in higher binding energy compared to the binding with three b-CDs. The docking results indicate that the 1:3 insulin-b-CD formation is the most stable conformation corresponding to the lowest binding free energy. Although the maximum number of b-CDs able to bind to insulin is four, the energy started to increase rapidly when we add more b-CD and no further binding was observed. The large difference between the binding energy of 1:3 complex with respect to the rest of the insulin-b-CD formation can be explained mainly as the binding of three b-CDs to the binding sites of insulin dimer contributed to stabilization of the insulin-cyclodextrin formation the most. As the binding energy is calculated as the difference in the total energy minus the energies of the free (unbound) molecules, it is therefore understood that the additional hydrogen bonds and hydrophobic interactions observed in the 1:4 insulinb-CD formation may not necessarily lower the binding energy of the complex. From the docking study, we believe the hydrophobic interactions as well the hydrogen bond formations are the main driving forces which contribute to the stabilization of the complex.
Molecular dynamics
To investigate the conformational stability of the human insulin dimer-b-CD formation, we then conducted a 50 ns MD simulation using the 1:3 insulin-b-CD final docked structure as the initial structure. The analysis was done on the basis of RMSDs, root mean square fluctuations (RMSFs) and the radius of gyration (Rg) of the free insulin and 1:3 insulin-b-CD formation with respect to its initial docked structure.
The RMSD values of the protein backbone atoms of each conformation with respect to its initial structure calculated along the 50 ns trajectories are shown in Fig. 5 .
The RMSD values of the 1:3 insulin-b-CD formation was slightly fluctuated at various simulation time and started to stabilize around the mean value 4.00 ± 0.50 Å at 38 ns. Whereas the free insulin system gave larger fluctuations (6.00 ± 1.00 Å ) and was not stable along the trajectories at the same simulation period. The small fluctuation of the RMSD values of the insulin-b-CD formation is indicating that the b-CDs are capable to stabilize the structure of human insulin dimer.
The radius of gyration (Rg) values of free insulin and 1:3 insulin-b-CD formation during 50 ns simulation are shown in Fig. 6 . The 1:3 insulin-b-CD formation was stabilized at about 30 ns, with the value of 13.50 ± 0.50 Å . The change in the gyration values of the free insulin system is expected to be due to the conformational rearrangements and stabilization in the insulin structure. The difference in the value of radius of gyration for the free insulin and 1:3 insulin-b-CD formation indicate that insulin dimer undergoes structural changes during its interaction with b-CDs.
The local mobility of atoms in the system was analyzed by calculating the root mean square fluctuations (RMSF). The RMSF profiles for the free insulin and 1: 3 insulin-b-CD systems are shown in Fig. 7 . The large fluctuations occured at residue number 22 (Phe22) and 42 (Glu42) in the B chain, 72 (Asn72) in A' chain, 73 (Phe73) and 93 (Glu93) in B' chain with the fluctuations distances of 5.720, 1.472, 2.679, 3.671 and 2.296 Å , respectively. The RMSF profiles for the free insulin system gave larger fluctuations (2.103-9.864 Å ) than the 1:3 insulin-b-CD systems at the same residues. This also proves that the complexation of insulin with b-CDs reduces the flexibility of atoms at certain residues. The large atomic fluctuations involving the amino acids residues located at the C-terminus of the B and B' chains of insulin dimer is consistent with the previous report by Pullen and co-workers [52] . In addition, the conformation at the C-terminus is also influenced by the N-terminus at B and B' chains [53] . Both systems (free insulin and insulin-b-CD formation) show the local atom mobility fluctuations which is due to the independent folding characteristic of insulin chains [35] or partial folding [54] which causes changes in the structural arrangement in insulin observed before. The changes in the total solvent accessible surface area (SASA) of free insulin and insulin-b-CD formation systems during the 50 ns simulation time is shown in Fig. 8 .
SASA was calculated by using a small probe molecule (H 2 O) with a radius of 1.4 Å that is theoretically rolled over the surface of the protein. The unfavourable contacts between water molecules and protein complex are proportional to the solvent accesible surface area values [55] . SASAs of the insulin-b-CD formation decreases initially and then stabilized at 800 Å 2 while that of the free insulin system remains constant at 650 ± 20.0 Å 2 . The decrease of SASA values in complex system is consistent with the hydrophobic interactions in the formation of the complex, thus, lessening the contacts between insulin and the water molecules. Figure 9 shows the details of the conformational changes over the simulation time course. It is observed that the first ten insulin residues change from turn shape to a-helix form. Another large change is also observed on residues number 60-70 located at the A' chain whereby initially the bend shape in the free insulin system changed to a-helix form in the insulin-b-CD formation at 46 ns and remains so until the end of the simulation. The interactions of b-CDs with the amino acid residues of insulin provided the stability to insulin-b-CD formation. The change to the a-helix conformation of the insulin structure comprises of about 80 % over the total configurational change in insulin dimer. In the previous study on insulin dimer stability by Falconi et al., the authors stated that a-helix configuration percentage were 49 and 39 % in monomers I and II, respectively. This was also supported experimentally [56] in which 43 and 39 % of a-helix conformation were recorded for monomer I and II of insulin dimer, respectively.
The analysis of the hydrogen bonds formation of the 1:3 insulin-b-CD system in the last 10 ns of simulation time is shown in Fig. 10 . In binding sites I and II, the highest numbers of hydrogen bonding formation was six and seven each. It was also observed that at all binding sites, the hydrogen bond formations between insulin and b-CD can be easily broken throughout the simulation time.
Conclusions
In this paper, multiple molecular docking and MD simulation were performed to investigate the interaction between human insulin dimer and b-cyclodextrin. The docking results showed that a maximum of four b-CDs could be bound to the insulin structure and the 1:3 insulinb-CD formation has the lowest binding free energy (-7.03 kcal/mol) while adding more b-CD to the system results in the increase in energy. Both docking and MD results are indicating the hydrophobic interactions play crucial roles in the stabilization of insulin-b-CDs formation in addition to the hydrogen bondings. The conformational stability of 1:3 insulin-b-CD formation was monitored by their RMSD values during the simulation process. The RMSF results also show the flexibility of the insulin structure was reduced, whereby the 1:3 insulin-b-CD formation tends to have less fluctuations and less structural change compared to the free insulin system. We believe our theoretical results could promote better understanding on the effect of b-CD(s) to the molecular properties of insulin and for the development of new oral insulin formulations in the future. 
